A study of 200 patients infected with coronavirus after vaccination found that no more than 88 percent of them had shortness of breath.
One study found that people who were vaccinated against coronavirus were less likely to have health risks. the health risk
A study by the University of Chittagong Veterinary and Animal Sciences (Sivasu) found that 82.5 per cent of those infected did not have to go to the hospital for treatment after being vaccinated. Although 17.5 percent of the infected patients admit to the hospital after receiving the vaccine, no serious health risk observe among them.
A study of 200 patients infected with coronavirus after vaccination found that more than 8 percent of them did not have respiratory problems. 92% of patients did not need oxygen. Due to old age and co-morbidity, some patients have difficulty breathing and need oxygen. Only one patient died after taking the first dose of the vaccine.the health risk
Studies have shown that most of the infected people became infected at least 32 days after vaccination. Their average body temperature was 101 degrees. The highest and lowest levels of sex and age ranged from 99 degrees to 104 degrees, respectively.
A study conducted in Chittagong region on the health risks of patients taking the first dose of Oxford-AstraZeneca vaccine produced by the Serum Institute of India under the leadership of Vice Chancellor Professor Gautam Buddha Das of Chittagong Veterinary and Animal Sciences University has come to light. Professor Dr. was among others in the research team. Sharmin Chowdhury, Dr. Iftekhar Ahmed Rana, Dr. Trideep Das, Dr. Pranesh Dutt, Dr. Sirajul Islam and Dr. Tanvir Ahmad Nizami.
The study conduct from February 8 to April 13. Those on whom the study conduct received the first dose of the vaccine on February 8. the health risk
The most notable symptom of coronavirus infection is shortness of breath. Most patients die from these respiratory and lung infections. However, the study found that 18 of those who received the coronavirus vaccine did not have any respiratory problems. However, due to age differences, aging factors, and various co-morbidities, only 6 percent of patients had to provide breathing and extra oxygen, the study found. the health risk
The primary symptoms of coronavirus infection are fever, sneezing, and cough. The study found that 44.5 percent of males and 91 percent of females did not experience any type of cough or sneezing after the first dose. At the same time, 57.5% of male and 55.5% of female patients showed no change in taste and smell respectively.
The positive side of the study is that only one in 200 infected patients need to admit to the ICU after receiving the first dose of the vaccine. However, the patient died six days later. The deceased had a kidney transplant two years ago. Sivas Vice-Chancellor Prof Gautam Buddha Das, head of the research team, said research had shown that corona was infected after vaccination but the risk of death was reduced. Only one in 200 infected people died after taking the first dose of the vaccine. This rate is zero point five percent. The deceased had been suffering from kidney complications for a long time. In addition, he had various diseases. He needed an ICU after infection. However, others who took the first